Languages
Pages
Legal
Explore all categories to find your favorite topic
Optimization of Drug-Eluting StentsSubmitted on 4 Sep 2013 HAL is a multi-disciplinary open access archive for the deposit and dissemination of sci- entific research documents,
Slide 1 ISAR-LEFT MAIN 2 Randomized Trial Zotarolimus- vs. Everolimus-Eluting Stents for Treatment of Unprotected Left Main Coronary Artery Lesions Julinda Mehilli, MD Klinikum…
2 Balloon Catheters 3 Cutting Balloon™ 4 Guidewires 5 Guide Catheters 6 Angiographic Catheters 7 Embolic Protection 8 IVUS 9 Atherectomy Devices 10 Accessory Products 1…
233 Dialogues in Cardiovascular Medicine - Vol 13 . No. 4 . 2008 Guest Editor - Eugene Braunwald, MD Guest Editorial Percutaneous coronary intervention: a contemporary assessment…
Accepted Manuscript Efficacy and Safety of the Absorb Everolimus-Eluting Bioresorbable Scaffold for Treatment of Patients with Diabetes Mellitus: Results of the Absorb Diabetic…
Slide 1 Angioplasty’s Fight against Restenosis: Drug Eluting Stents & Bare Metal Stents Slide 2 Balloon Angioplasty minimally invasive treatment to open blocked arteries.…
New generation DES: which role in ACS?METCARDIO, Ospedaletti, Italy www.metcardio.org Why could drug-eluting stents possibly be safer than bare-metal stents? The case for
Microsoft PowerPoint - 1.Young-Keun AhnAcute Myocardial InfarctionAcute Myocardial Infarction YoungkeunYoungkeun AhnAhn, MD, PhD, MD, PhD Heart CenterHeart Center ChonnamChonnam
1. Ajay J. Kirtane, MD, SMCenter for Interventional Vascular TherapyColumbia University Medical Center /New York Presbyterian HospitalDrug-Eluting Stents forMultivessel PCI:Indications…
Drug Eluting Versus Bare Metal Stents Prof. Dr. Raouf Mahran ;MRCP Prof. of cardiovasc. Med National Heart Institute 2009 Evolution of PCI 1977: Balloon Angioplasty (POBA)…
__________ (acronym) TrialM Leon, TCT 2006 Valgimigli M et al. JAMA 2005; 293:2109-2117. 2. Spaulding C et al. NEJM 2006; 355:1093-104. 3. Menichelli M. EuroPCR 2006. 4.
Bare Metal and Drug Eluting Stents Bare Metal vs Drug Eluting Stents Should DES be the chosen one? Class 22, 1st year Adviser: Prof. Filipa Almeida Authors: Aguiar, A.; Alves,…
Sirolimus-eluting Stents: Present and Future Dr Steve Fearn Director of Health Economics and Medical Affairs Cordis UK Conflict of Interest I am employed by Cordis. Topics…
PowerPoint Presentation Drug Eluting Coronary Stent Coatings Part 10: Drug Eluting Heart Stent Coatings 1 Copyright ©1996 American Heart Association Edelman, E. R. et al.…
Hindawi Publishing Corporation ISRN Cardiology Volume 2013 Article ID 748736 8 pages http:dxdoiorg1011552013748736 Review Article Risk Factors for Coronary Drug-Eluting Stent…
HEAD OFFICE: 5751 Copley Drive Suite B San Diego CA 92111 • +1 858 966-3000 • +1 858 966-3099 FAX • wwwrevamedicalcom AUSTRALIAN OFFICE: Level 6 175 Macquarie Street…
English Deutsch Svenska Dansk Polski Česky Türkçe Norsk Italiano Suomi Français Español Pусский Português Nederlands Ελληνικά Magyar Български…
Patient Information Guide Everolimus Eluting Coronary Stent System 33 Coronary Artery Disease CAD ........................5 Your Heart ........................................................5…
Slide 1Prospective, Randomized Trial of Paclitaxel- versus Sirolimus- Eluting Stents for Treatment of Coronary Restenosis in Sirolimus-Eluting Stents Robert A. Byrne, Julinda…
Drug Eluting Stents overhyped, overused and overpriced? William Wijns MD, PhD Cardiovascular Center Aalst http://www.cardio-aalst.be [email protected] Advanced…